Side-by-side comparison of AI visibility scores, market position, and capabilities
Texas supermarket institution with $38B revenue and near-mythological loyalty; emergency response excellence and Texas-specific private label dominating markets with community trust.
H-E-B is a Texas-based regional supermarket chain that has become one of the most admired and beloved grocers in the United States — known for exceptional fresh food departments, Texas-specific private label products, community involvement, and a customer service culture that has created extraordinary loyalty among Texas consumers. Privately owned by the Butt family (Charles Butt is chairman), H-E-B generates approximately $38 billion in annual revenue from approximately 420 stores in Texas and Mexico, making it one of the largest private companies in the United States.\n\nH-E-B's operational excellence is legendary — the company's emergency response during natural disasters (Hurricane Harvey 2017, the 2021 Texas winter storm Uri) where H-E-B deployed mobile kitchens and supply chains before government agencies has earned it near-mythological status in Texas. The store formats range from compact Market and Mi Tienda formats in urban and Hispanic-focused markets to the flagship Central Market (a premium specialty grocery experience that competes with Whole Foods) and the H-E-B Plus stores with expanded departments.\n\nIn 2025, H-E-B competes with Kroger, Walmart, Costco, and Amazon for Texas grocery market share and holds a dominant position in many Texas markets where its customer loyalty creates an essentially unassailable competitive moat. The company launched Favor (its same-day delivery service, competing with Instacart and DoorDash Grocery) and has invested significantly in digital ordering and same-day fulfillment. H-E-B's Texas-specific private label products (Central Market Organics, H-E-B brand items, Texas-style BBQ sauces) create regional differentiation that national chains cannot replicate. The 2025 strategy focuses on selective geographic expansion in Texas, digital order fulfillment investment, and continuing its community investment programs.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.